Axerion Therapeutics Inc.

Biopharma companies closed 70 deals around the four major neurodegenerative diseases – Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Amyotrophic Lateral Sclerosis – in the period Jan

AstraZeneca PLC became the latest pharma to strike a deal with Vanderbilt University Medical Center to discover and develop neurology drug candidates, inking a two-year research deal with the un

[Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog .] Every player in big pharma is facing a

[Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog .] While many big pharmas have shied away